3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor
Conditions
Endometrial Neoplasms
6
Neoplasms
5
Colonic Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Uterine Cervical Neoplasms
2
Neoplasm Metastasis
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H)
1
Penile Neoplasms
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ovarian Carcinosarcoma
1
Neoplasms, Second Primary
1
Locally Advanced Rectal Cancer (LARC)
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Carcinoma
1
Breast Neoplasms
1
Brain Neoplasms
1
Adrenocortical Carcinoma
1
Interventions
pembrolizumab
12
Cisplatin
7
Cetuximab
7
Carboplatin
7
Docetaxel
6
Blood Specimen Collection
4
Radiotherapy, Intensity-Modulated
3
Paclitaxel
3
toripalimab
2
atezolizumab
2
Radiotherapy
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Fluorouracil
2
Drug Therapy
2
tocilizumab
1
regorafenib
1
osimertinib
1
lenvatinib
1
fludarabine
1
ficlatuzumab
1
cemiplimab
1
calcipotriene
1
bintrafusp alfa protein, human
1
avelumab
1
alpha-2'-deoxythioguanosine
1
aldesleukin
1
aflibercept
1
Watchful Waiting
1
Vinorelbine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Squamous Cell
×
dostarlimab
×
Clear all
No trials found.